Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide vs Sulphonylurea during Ramadan in T2DM
NCT01917656Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Jan 2014
- Primary completion
- Sep 2014
- Modality
- Peptides
- Countries
- 7
01
Overview
A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Jan 2014; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01917656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01917656.